Followers | 1335 |
Posts | 257302 |
Boards Moderated | 60 |
Alias Born | 12/07/2009 |

Tuesday, March 11, 2025 8:59:43 AM

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Recent COEP News
- Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline • GlobeNewswire Inc. • 03/11/2025 12:34:00 PM
- COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan • GlobeNewswire Inc. • 03/07/2025 01:37:00 PM
- COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network • GlobeNewswire Inc. • 02/20/2025 02:00:00 PM
- COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing • GlobeNewswire Inc. • 02/20/2025 12:27:00 PM
- COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing • GlobeNewswire Inc. • 02/19/2025 09:00:00 PM
- COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • InvestorsHub NewsWire • 02/13/2025 02:10:07 PM
- COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • GlobeNewswire Inc. • 02/13/2025 01:39:00 PM
- COEPTIS Completes $10 Million Series A Preferred Financing Round, Reinforcing Commitment to Technological Innovation and AI Integration • PR Newswire (US) • 02/06/2025 01:08:00 PM
- Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation • PR Newswire (US) • 01/30/2025 01:27:00 PM
- Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation • PR Newswire (US) • 01/23/2025 01:09:00 PM
- Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2) • PR Newswire (US) • 01/22/2025 01:00:00 PM
- Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform • PR Newswire (US) • 01/07/2025 01:00:00 PM
- Trading Halt Occurred During This Micro Cap's EOY Surge • AllPennyStocks.com • 12/31/2024 07:20:00 PM
- Coeptis Therapeutics Announces Reverse Stock Split • PR Newswire (US) • 12/27/2024 01:15:00 PM
- Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies • PR Newswire (US) • 12/26/2024 01:15:00 PM
- Coeptis Therapeutics Unveils New Technology Division: Coeptis Technologies • PR Newswire (US) • 12/12/2024 01:00:00 PM
- Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries • PR Newswire (US) • 12/03/2024 01:15:00 PM
- Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development • PR Newswire (US) • 11/07/2024 01:07:00 PM
- Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use • PR Newswire (US) • 10/24/2024 12:07:00 PM
- Coeptis Therapeutics' Chief Scientific and Medical Officer to Present at Upcoming Fall Conferences, Highlighting Progress in Universal Cell Therapy • PR Newswire (US) • 10/15/2024 12:07:00 PM
- Coeptis Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing • PR Newswire (US) • 09/19/2024 11:07:00 AM
- Coeptis Therapeutics Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders • PR Newswire (US) • 09/05/2024 12:07:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 08:02:33 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 08:01:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:26:34 PM
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates • LFLRF • Mar 21, 2025 9:40 AM
Basanite Industries, Inc. Appoints Michael D. Nelson as Chief Executive Officer • BASA • Mar 21, 2025 9:01 AM
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation • FITY • Mar 20, 2025 9:00 AM
VAYK Forms Partnership with Airbnb Investing Group to Offer Service Solution • VAYK • Mar 20, 2025 9:00 AM
4Cable TV International, Inc. (CATV) Facilitates Acquisition of Genetic Networks LLC by Fifty 1 Labs, Inc. (FITY), Announces Dividend for CATV Shareholders, and Sets Stage for Transformative Reverse Merger • CATV • Mar 20, 2025 8:30 AM
NUBURU Announces Elimination of 100% of its Long-Term Indebtedness and $5.15 Million Strategic Investment in Supply@ME Capital • BURU • Mar 19, 2025 8:53 AM